Press Releases

Press Release

Cardiol Therapeutics to Commence Trading on NASDAQ Under the Symbol “CRDL”

August 09, 2021

Press Release

Cardiol Therapeutics’ Board of Directors Appoints Dr. Guillermo Torre-Amione as Chairman

July 07, 2021

Press Release

Cardiol Therapeutics Reports Results of 2021 Annual General and Special Meeting

June 30, 2021

Press Release

Cardiol Therapeutics to Webcast Virtual Annual General and Special Meeting on June 29th at 4:30 p.m. EDT

June 28, 2021

Press Release

Cardiol Therapeutics Closes $22 Million Bought Deal Offering

May 12, 2021

Press Release

Cardiol Announces Upsize to Previously Announced Bought Deal Public Offering

May 06, 2021

Press Release

Cardiol Therapeutics Announces $15 Million Bought Deal Public Offering

May 05, 2021

Press Release

Cardiol Therapeutics Announces First Patient Enrolled in LANCER, a Phase II/III Outcomes Trial in High-risk Patients Hospitalized with COVID-19

April 28, 2021

Press Release

Cardiol Therapeutics Announces Topline Results from Phase I Single and Multiple Ascending Dose Clinical Trial of CardiolRx™

April 12, 2021